Protocol TOP-Study (tacrolimus organ perfusion): A prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion

Transplantation Research

Volumn 2, Issue 1, 2013, Pages

  Pratschke, Sebastian ^a   Eder, Michael ^a   Heise, Michael ^b   Nadalin, Silvio ^c   Pascher, Andreas ^d   Schemmer, Peter ^e   Scherer, Marcus N ^f   Ulrich, Frank ^g   Wolters, Heiner ^h   Jauch, Karl Walter ^a   Wöhling, Dirk ⁱ   Angele, Martin K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h UNIVERSITY HOSPITAL MÜNSTER   (Germany)

ⁱ DABIO Gesellschaft für Auftragsforschung mbH   (Germany)

Author keywords

Extended donor criteria; Graft function; Graft survival; Liver transplantation; Marginal grafts; Organ rinse; Organ shortage; Tacrolimus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PLACEBO; PROTHROMBIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HYPOTHESIS; LIVER TRANSPLANTATION; MULTICENTER STUDY; ORGAN PERFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SAMPLE SIZE;

EID: 84885404717     PISSN: None     EISSN: 20471440     Source Type: Journal    
DOI: 10.1186/2047-1440-2-3     Document Type: Article

References (44)

1. Hasegawa T, Ito Y, Wijeweera J, Liu J, Malle E, Farhood A, McCuskey RS, Jaeschke H. Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am J Physiol Gastrointest Liver Physiol 2007, 292(5):G1385-G1395.
2. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993, 56(5):1076-1082. 10.1097/00007890-199311000-00005, 8249103.
3. Nardo B, Caraceni P, Pasini P, Domenicali M, Catena F, Cavallari G, Santoni B, Maiolini E, Grattagliano I, Vendemiale G, Trevisani F, Roda A, Bernardi M, Cavallari A. Increased generation of reactive oxygen species in isolated rat fatty liver during postischemic reoxygenation. Transplantation 2001, 71(12):1816-1820. 10.1097/00007890-200106270-00018, 11455263.
4. Angele MK, Rentsch M, Hartl WH, Wittmann B, Graeb C, Jauch KW, Loehe F. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008, 195(2):214-220. 10.1016/j.amjsurg.2007.02.023, 18154767.
5. Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, Garcia-Valdecasas JC, Salizzoni M, Moreno GE, Mirza D. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006, 81(1):7-14. 10.1097/01.tp.0000188619.30677.84, 16421468.
6. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003, 284(1):G15-G26.
7. Jaeschke H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. Invest Surg 2003, 16(3):127-140.
8. Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000, 32(3):508-515. 10.1016/S0168-8278(00)80404-3, 10735623.
9. Raina A, Horn ET, Benza RL. The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists. Transplantation 2012, 94(9):885-893. 10.1097/TP.0b013e31825f0fbe, 23037008.
10. Abu-Amara M, Yang SY, Seifalian A, Davidson B, Fuller B. The nitric oxide pathway-evidence and mechanisms for protection against liver ischaemia reperfusion injury. Liver Int 2012, 32(4):531-543. 10.1111/j.1478-3231.2012.02755.x, 22316165.
11. Sun CK, Zhang XY, Zimmermann A, Davis G, Wheatley AM. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 2001, 72(10):1625-1631. 10.1097/00007890-200111270-00008, 11726821.
12. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation 2003, 10(6):447-456.
13. Pratschke S, Loehe F, Graeb C, Jauch KW, Angele MK. Usage of marginal organs for liver transplantation: a way around the critical organ shortage?. Zentralbl Chir 2009, 134(2):107-112. 10.1055/s-0028-1098880, 19382040.
14. Pratschke S, Bilzer M, Grutzner U, Angele M, Tufman A, Jauch KW, Schauer RJ. Tacrolimus preconditioning of rat liver allografts impacts glutathione homeostasis and early reperfusion injury. J Surg Res 2012, 176(1):309-316. 10.1016/j.jss.2011.07.045, 21962731.
15. Sakr MF, Zetti GM, Farghali H, Hassanein TH, Gavaler JS, Starzl TE. Protective effect of FK 506 against hepatic ischemia in rats. Transplant Proc 1991, 23(1 Pt 1):340-341. 2972717, 1703689.
16. Kawano K, Bowers JL, Clouse ME. Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. Transplant Proc 1995, 27(1):362-363.
17. Kawano K, Bowers JL, Kim YI, Tatsuma T, Kitano S, Kobayashi M, Clouse ME. FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation. Transplant Proc 1996, 28(3):1902-1903.
18. Garcia-Criado FJ, Palma-Vargas JM, Valdunciel-Garcia JJ, Toledo AH, Misawa K, Gomez-Alonso A, Toledo-Pereyra LH. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation 1997, 64(4):594-598. 10.1097/00007890-199708270-00008, 9293871.
19. Takeichi T, Uemoto S, Minamiguchi S, Takeyoshi I, Inomata Y, Tanaka K, Kobayashi E. Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver. World J Gastroenterol 2009, 15(45):5712-5715. 10.3748/wjg.15.5712, 2789225, 19960569.
20. Huser N, Doll D, Altomonte J, Werner M, Kriner M, Preissel A, Thorban S, Matevossian E. Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat. Arch Pharm Res 2009, 32(2):215-220. 10.1007/s12272-009-1138-9, 19280151.
21. Eurotransplant International Foundation Eurotransplant Manual 2009, Leiden: Eurotransplant International Foundation, Eurotransplant International Foundation.
22. Peter S, Post DJ, Rodriguez-Davalos MI, Douglas DD, Moss AA, Mulligan DC. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transpl 2003, 9(2):144-149. 10.1053/jlts.2003.50018, 12548508.
23. Pratschke S, Angele MK, Grutzner U, Tufman A, Bilzer M, Loehe F, Jauch KW, Schauer RJ. GSH attenuates organ injury and improves function after transplantation of fatty livers. Eur Surg Res 2010, 45(1):13-19. 10.1159/000316643, 20689302.
24. Schauer RJ, Kalmuk S, Gerbes AL, Leiderer R, Meissner H, Schildberg FW, Messmer K, Bilzer M. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World J Gastroenterol 2004, 10(6):864-870.
25. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, O'Grady JG, Castaing D, Klempnauer J, Jamieson N, Neuhaus P, Lerut J, de Ville de Goyet J, Pollard S, Salizzoni M, Rogiers X, Muhlbacher F, Garcia Valdecasas JC, Broelsch C, Jaeck D, Berenguer J, Gonzalez EM, Adam R, European Liver Transplant Association 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006, 367(9506):225-232. 10.1016/S0140-6736(06)68033-1, 16427491, European Liver Transplant Association.
26. Adam R, Cailliez V, Majno P, Karam V, McMaster P, Caine RY, O'Grady J, Pichlmayr R, Neuhaus P, Otte JB, Hoeckerstedt K, Bismuth H. Normalised intrinsic mortality risk in liver transplantation: European liver transplant registry study. Lancet 2000, 356(9230):621-627. 10.1016/S0140-6736(00)02603-9, 10968434.
27. Banerji SS, Parsons JN, Tocci MJ. The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1. Mol Cell Biol 1991, 11(8):4074-4087. 361217, 1712901.
28. Yoshimura N, Matsui S, Hamashima T, Oka T. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. Transplantation 1989, 47(2):351-356. 10.1097/00007890-198902000-00034, 2465592.
29. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997, 100(2):279-289. 10.1172/JCI119533, 508190, 9218504.
30. Khandoga A, Hanschen M, Kessler JS, Krombach F. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 2006, 43(2):306-315. 10.1002/hep.21017, 16440342.
31. Shen X, Wang Y, Gao F, Ren F, Busuttil RW, Kupiec-Weglinski JW, Zhai Y. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009, 50(5):1537-1546. 10.1002/hep.23153, 2805281, 19670423.
32. Zhang Y, Ji H, Shen X, Cai J, Gao F, Koenig KM, Batikian CM, Busuttil RW, Kupiec-Weglinski JW. Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. Am J Transplant 2012, 8:10-6143.
33. Hanschen M, Zahler S, Krombach F, Khandoga A. Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia-reperfusion. Transplantation 2008, 86(5):710-718. 10.1097/TP.0b013e3181821aa7, 18791453.
34. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991, 260(3 Pt 1):G355-G362.
35. Yadav SS, Howell DN, Gao W, Steeber DA, Harland RC, Clavien PA. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1998, 275(6 Pt 1):G1341-G1352.
36. Squadrito F, Altavilla D, Squadrito G, Saitta A, Deodato B, Arlotta M, Minutoli L, Quartarone C, Ferlito M, Caputi AP. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury. J Mol Cell Cardiol 2000, 32(3):429-440. 10.1006/jmcc.1999.1089, 10731442.
37. Garcia-Criado FJ, Lozano-Sanchez F, Fernandez-Regalado J, Valdunciel-Garcia JJ, Parreno-Manchado F, Silva-Benito I, Zambrano-Cuadrado Y, Gomez-Alonso A. Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. Transplantation 1998, 66(7):942-943. 10.1097/00007890-199810150-00028, 9798713.
38. Tojimbara T, Bermudez LE, Egawa H, Hayashi M, So SK, Esquivel CO. Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. Transplant Proc 1996, 28(3):1381-1382.
39. Kristo I, Wilflingseder J, Kainz A, Marschalek J, Wekerle T, Mühlbacher F, Oberbauer R, Bodingbauer M. Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial. Transpl Int 2011, 24(9):912-919. 10.1111/j.1432-2277.2011.01284.x, 3359429, 21672049.
40. Soda Y, el-Assal ON, Yu L, Nagasue N. Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia/reperfusion of rat small intestine. Surgery 1999, 125(1):23-32. 10.1016/S0039-6060(99)70284-9, 9889794.
41. Gomez-Lechon MJ, Serralta A, Donato MT, Jimenez N, O'connor E, Castell JV, Mir J. The immunosuppressant drug FK506 prevents Fas-induced apoptosis in human hepatocytes. Biochem Pharmacol 2004, 68(12):2427-2433. 10.1016/j.bcp.2004.08.028, 15548389.
42. Crenesse D, Laurens M, Heurteaux C, Cursio R, Saint-Paul MC, Schmid-Alliana A, Gugenheim J. Rat liver ischemia-reperfusion-induced apoptosis and necrosis are decreased by FK506 pretreatment. Eur J Pharmacol 2003, 473(2-3):177-184.
43. Puhl G, Schaser KD, Pust D, Kohler K, Vollmar B, Menger MD, Neuhaus P, Settmacher U. Initial hepatic microcirculation correlates with early graft function in human orthotopic liver transplantation. Liver Transpl 2005, 11(5):555-563. 10.1002/lt.20394, 15838880.
44. Pratschke J, Weiss S, Neuhaus P, Pascher A. Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation. Transpl Int 2008, 21(6):512-522. 10.1111/j.1432-2277.2008.00643.x, 18266771.